Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Postponement, 62746 [2020-21939]
Download as PDF
<![CDATA[
62746
Federal Register / Vol. 85, No. 193 / Monday, October 5, 2020 / Notices
The
meeting of the Circulatory System
Devices Panel of the Medical Devices
Advisory Committee was originally
announced in the Federal Register of
August 20, 2020 (85 FR 51453), and was
initially scheduled for October 7, 2020.
FDA has decided to postpone this
public meeting until further notice.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2020–21952 Filed 10–2–20; 8:45 am]
BILLING CODE 4164–01–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 29, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
Food and Drug Administration
[Docket No. FDA–2020–N–0008]
[FR Doc. 2020–21939 Filed 10–2–20; 8:45 am]
Circulatory System Devices Panel of
the Medical Devices Advisory
Committee; Notice of Meeting;
Postponement
AGENCY:
BILLING CODE 4164–01–P
Food and Drug Administration,
HHS.
Health Resources and Services
Administration
Notice of meeting;
postponement.
ACTION:
The Food and Drug
Administration (FDA) is postponing the
meeting of the Circulatory System
Devices Panel of the Medical Devices
Advisory Committee scheduled from
October 7, 2020, to a later date to be
determined. The meeting was
announced in the Federal Register of
August 20, 2020. A future meeting date
will be announced in the Federal
Register.
SUMMARY:
jbell on DSKJLSW7X2PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Aden Asefa, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5214, Silver Spring,
MD 20993–0002, Aden.Asefa@
fda.hhs.gov, 301–796–0400, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area) and follow the
prompts to the desired center or product
area. Please call the Information Line for
up-to-date information on this meeting.
VerDate Sep<11>2014
23:42 Oct 02, 2020
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Jkt 253001
Agency Information Collection
Activities: Submission to OMB for
Review and Approval: Public Comment
Request; Information Collection
Request Title: Application for Deemed
Health Center Program Award
Recipients To Sponsor Volunteer
Health Professionals for Deemed PHS
Employment
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with of the
Paperwork Reduction Act of 1995,
HRSA has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period. OMB may act on
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
HRSA’s ICR only after the 30 day
comment period for this notice has
closed.
Comments on this ICR must be
received no later than November 4,
2020.
DATES:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under Review—Open for
Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email Lisa
Wright-Solomon, the HRSA Information
Collection Clearance Officer at
paperwork@hrsa.gov or call (301) 443–
1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
Application for Deemed Health Center
Program Award Recipients to Sponsor
Volunteer Health Professionals for
Deemed PHS Employment, OMB No.
0915–0032—Revision.
Abstract: Subsection 224(q) to the
Public Health Service (PHS) Act (42
U.S.C. 233(q)), extended liability
protections for the performance of
medical, surgical, dental, and related
functions to Volunteer Health
Professionals (VHPs) of health centers
that have also been deemed as
employees of the PHS for this purpose.
Through the process established by
HRSA, VHPs of deemed health centers
may be deemed as PHS employees for
ADDRESSES:
E:\FR\FM\05OCN1.SGM
05OCN1
EN05OC20.072</GPH>
Dated: September 29, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
]]>Agencies
[Federal Register Volume 85, Number 193 (Monday, October 5, 2020)]
[Notices]
[Page 62746]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21939]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2020-N-0008]
Circulatory System Devices Panel of the Medical Devices Advisory
Committee; Notice of Meeting; Postponement
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of meeting; postponement.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is postponing the
meeting of the Circulatory System Devices Panel of the Medical Devices
Advisory Committee scheduled from October 7, 2020, to a later date to
be determined. The meeting was announced in the Federal Register of
August 20, 2020. A future meeting date will be announced in the Federal
Register.
FOR FURTHER INFORMATION CONTACT: Aden Asefa, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5214, Silver Spring, MD 20993-0002,
[email protected], 301-796-0400, or FDA Advisory Committee
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC
area) and follow the prompts to the desired center or product area.
Please call the Information Line for up-to-date information on this
meeting.
SUPPLEMENTARY INFORMATION: The meeting of the Circulatory System
Devices Panel of the Medical Devices Advisory Committee was originally
announced in the Federal Register of August 20, 2020 (85 FR 51453), and
was initially scheduled for October 7, 2020. FDA has decided to
postpone this public meeting until further notice.
Dated: September 29, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2020-21939 Filed 10-2-20; 8:45 am]
BILLING CODE 4164-01-P
